Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-24-001053
Filing Date
2024-10-31
Accepted
2024-10-31 17:03:01
Documents
65
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q novaccess20240630_10q.htm   iXBRL 10-Q 1282690
2 EXHIBIT 31.1 ex_737768.htm EX-31.1 8085
3 EXHIBIT 31.2 ex_737769.htm EX-31.2 7958
4 EXHIBIT 32.1 ex_737770.htm EX-32.1 3443
  Complete submission text file 0001185185-24-001053.txt   7141887

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA xsnx-20240630.xsd EX-101.SCH 45778
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xsnx-20240630_cal.xml EX-101.CAL 28967
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xsnx-20240630_def.xml EX-101.DEF 268833
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE xsnx-20240630_lab.xml EX-101.LAB 402971
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xsnx-20240630_pre.xml EX-101.PRE 276137
67 EXTRACTED XBRL INSTANCE DOCUMENT novaccess20240630_10q_htm.xml XML 970577
Mailing Address 8584 E. WASHINGTON STREET, NO. 127 CHAGRIN FALLS OH 44023
Business Address 8584 E. WASHINGTON STREET, NO. 127 CHAGRIN FALLS OH 44023 (213) 642-9268
NovAccess Global Inc. (Filer) CIK: 0001039466 (see all company filings)

EIN.: 841384159 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-29621 | Film No.: 241416059
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)